Home
Invus Global Management reported a 4.7% stake in Neumora Therapeutics NMRA · 8,497,822 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.7%
- Last report
- 5.4% · filed 26/02/19
- Shares held
- 8,497,822 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Invus Global Management
- Event date
- 26/03/31
- Filed
- 26/05/04
4.7% stake · below 5%
- Stake
- 4.7%
- Last report
- 5.4%
- Since last report
- −0.7pp
Neumora Therapeutics trades, last 26 weeks
What else happened in Neumora Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Invus Global Management's other 5% stake reports
- Invus Global Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
7.2% stake
675,000 sh
7.2% stake
Filed 09/17
- Invus Global Management
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
9.3% stake
6,256,662 sh
9.3% stake
Filed 08/13
- Invus Global Management
5% stakeScholar Rock Holding
5% stakeScholar Rock Holding
SRRK
8% stake
9,575,013 sh
8% stake
Filed 08/13
- Invus Global Management
5% stakeAbivax
5% stakeAbivax
ABVX
6% stake
4,825,759 sh
6% stake
Filed 08/13
- Invus Global Management
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
5.1% stake
2,366,235 sh
5.1% stake
Filed 08/07
